[Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study].
Conclusions: Esomeprazole BD was as effective as esomeprazole OD in improving GERD-related NCCP. Although statistically insignificant, the percentage of patients with >50% reduction in the chest pain score was higher in the esomeprazole BD group than in the esomeprazole OD group. Large-scale studies will be needed to assess these findings further.
PMID: 32581204 [PubMed - in process]
Source: Korean J Gastroenter... - Category: Gastroenterology Authors: Choi JK, Shim HI, Shin CM, Yoon H, Park YS, Kim N, Lee DH Tags: Korean J Gastroenterol Source Type: research
More News: Acid Reflux | Cardiology | Coronary Heart Disease | Esomeprazole | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Heart | Heart Disease | Nexium | Pain | Proton Pump Inhibitors PPIs | Statistics | Study